Zika Virus Vaccines


The live-attenuated vaccine is developed for the disease caused by Zika Virus. The monovalent version of the vaccine is designed against Zika virus infection. Zika Virus belongs to the Genus Flavivirus, which is transmitted by the Aedes mosquitos.  The understanding of flavivirus particle structure, the definition of E dimers as the key antigenic target, and a deep understanding of neutralization mechanisms help to develop the vaccine.


    Related Conference of Zika Virus Vaccines

    May 22-23, 2023

    41st Euro Global Summit and Expo on Vaccines & Vaccination

    Berlin, Germany
    July 31-01, 2023

    35th International Conference on Vaccines and Immunization

    Vancouver, Canada
    August 21-22, 2023

    6th International Conference on Vaccines and Immunology

    Paris, France
    October 18-19, 2023

    43rd Global Summit and Expo on Vaccines & Immunology

    Vienna, Austria
    November 04-05, 2023

    35th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada
    November 06-07, 2023

    5th World Congress on Vaccine and Immunology

    Tokyo, Japan
    February 08-09, 2024

    International Conference on Vaccine Research

    Madrid, Spain
    March 20-21, 2024

    7th International Conference on Vaccines, Immunology and Clinical Trials

    Amsterdam, Netherlands

    Zika Virus Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in